Virtual reality tested to ease breathlessness in ALS

NCT ID NCT06021938

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether immersive virtual reality (IVR) can reduce persistent shortness of breath in people with ALS who already use a breathing machine (non-invasive ventilation). 35 participants will try both a VR session based on medical hypnosis and a music therapy session. The goal is to see if these techniques can improve comfort and reduce breathing discomfort.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Immersive virtual reality (IVR) and music therapy
What this could lead to
If it works, this could offer a drug-free way to help ALS patients feel less breathless between ventilation sessions.
What could go wrong
This is a very small, early-stage study with only 35 participants. The effect may be small or not last, and results may not apply to all ALS patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AMYOTROPHIC LATERAL SCLEROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Service de Pneumologie

    RECRUITING

    Paris, France, 75013, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.